Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral

Virology

Volumn 411, Issue 2, 2011, Pages 180-193

  Samuel, Charles E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ADAR; Double stranded RNA; Innate immunity; Interferon; RNA editing

Indexed keywords

ADAR1 P110 PROTEIN; ADAR1 P150 PROTEIN; ADAR2A PROTEIN; ADAR2R PROTEIN; ADENOSINE DEAMINASE; PEGINTERFERON ALPHA; RIBAVIRIN; UNCLASSIFIED DRUG;

ADENOSINE DEAMINASE ACTING ON RNA 1 GENE; ADENOSINE DEAMINASE ACTING ON RNA 2 GENE; ADENOSINE DEAMINASE ACTING ON RNA 3 GENE; AMINO ACID SUBSTITUTION; CELLULAR DISTRIBUTION; CYTOPATHOGENIC EFFECT; EPSTEIN BARR VIRUS; GENE; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEASLES VIRUS; MOUSE POLYOMA VIRUS; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PARAMYXOVIRUS; POLYOMA VIRUS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RETROVIRUS; REVIEW; RIFT VALLEY FEVER BUNYAVIRUS; RNA DEGRADATION; RNA EDITING; RNA REPLICATION; RNA SPLICING; RNA STRUCTURE; RNA TRANSLATION; VESICULAR STOMATITIS VIRUS; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS REPLICATION;

ADENOSINE DEAMINASE; ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; MAMMALS; RNA EDITING; RNA VIRUSES; RNA, DOUBLE-STRANDED; RNA, VIRAL; SUBSTRATE SPECIFICITY;

MAMMALIA;

EID: 79952069367     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.12.004     Document Type: Review

References (198)

1. Agranat L., Raitskin O., Sperling J., Sperling R. The editing enzyme ADAR1 and the mRNA surveillance protein hUpf1 interact in the cell nucleus. Proc. Natl Acad. Sci. USA 2008, 105:5028-5033.
2. Amexis G., Rubin S., Chizhikov V., Pelloquin F., Carbone K., Chumakov K. Sequence diversity of Jeryl Lynn strain of mumps virus: quantitative mutant analysis for vaccine quality control. Virology 2002, 300:171-179.
3. Appel N., Schaller T., Penin F., Bartenschlager R. From structure to function: new insights into hepatitis C virus RNA replication. J. Biol. Chem. 2006, 281:9833-9836.
4. Arnaud N., Dabo S., Maillard P., Budkowska A., Kalliampakou K.I., Mavromara P., Garcin D., Hugon J., Gatignol A., Akazawa D., Wakita T., Meurs E.F. Hepatitis C virus controls interferon production through PKR activation. PLoS ONE 2010, 5:e10575. 10.1371/journal.pone.0010575.
5. Athanasiadis A., Rich A., Maas S. Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol. 2004, 2:e391.
6. Baczko K., Lampe J., Liebert U.G., Brinckmann U., ter Meulen V., Pardowitz I., Budka H., Cosby S.L., Isserte S., Rima B.K. Clonal expansion of hypermutated measles virus in a SSPE brain. Virology 1993, 197:188-195.
7. Bass B.L. RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 2002, 71:817-846.
8. Bass B.L., Weintraub H. A developmentally regulated activity that unwinds RNA duplexes. Cell 1987, 48:607-613.
9. Bass B.L., Weintraub H. An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 1988, 55:1089-1098.
10. Bass B.L., Nishikura K., Keller W., Seeburg P.H., Emeson R.B., O'Connell M.A., Samuel C.E., Herbert A. A standardized nomenclature for adenosine deaminases that act on RNA. RNA 1997, 3:947-949.
11. Berkhout B., Jeang K.T. RISCy business: MicroRNAs, pathogenesis, and viruses. J. Biol. Chem. 2007, 282:26641-26645.
12. Billecocq A., Spiegel M., Vialat P., Kohl A., Weber F., Bouloy M., Haller O. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J. Virol. 2004, 78:9798-9806.
13. Brass A.L., Dykxhoorn D.M., Benita Y., Yan N., Engelman A., Xavier R.J., Lieberman J., Elledge S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319:921-926.
14. Burns C.M., Chu H., Rueter S.M., Hutchinson L.K., Canton H., Sanders-Bush E., Emeson R.B. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 1997, 387:303-308.
15. Bushman F.D., Malani N., Fernandes J., D'Orso I., Cagney G., Diamond T.L., Zhou H., Hazuda D.J., Espeseth A.S., König R., Bandyopadhyay S., Ideker T., Goff S.P., Krogan N.J., Frankel A.D., Young J.A., Chanda S.K. Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog. 2009, 5:e1000437.
16. Carpenter J.A., Keegan L.P., Wilfert L., O'Connell M.A., Jiggins F.M. Evidence for ADAR-induced hypermutation of the Drosophila sigma virus (Rhabdoviridae). BMC Genet. 2009, 10:75. 10.1186/1471-2156-10-75.
17. Casey J.L. RNA editing in hepatitis delta virus. Curr. Top. Microbiol. Immunol. 2006, 307:67-89.
18. Cattaneo R., Billeter M.A. Mutations and A/I hypermutations in measles virus persistent infections. Curr. Top. Microbiol. Immunol. 1992, 176:63-74.
19. Cattaneo R., Schmid A., Rebmann G., Baczko K., Ter Meulen V., Bellini W.J., Rozenblatt S., Billeter M.A. Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis: interrupted matrix protein reading frame and transcription alteration. Virology 1986, 154:97-107.
20. Cattaneo R., Schmid A., Eschle D., Baczko L., ter Meulen V., Billeter M.A. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 1988, 55:255-265.
21. Chambers P., Rima B.K., Duprex W.P. Molecular differences between two Jeryl Lynn mumps virus vaccine component strains, JL5 and JL2. J. Gen. Virol. 2009, 90:2973-2981.
22. Chen C.X., Cho D.S., Wang Q., Lai F., Carter K.C., Nishikura K. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA 2000, 6:755-767.
23. Chilibeck K.A., Wu T., Liang C., Schellenberg M.J., Gesner E.M., Lynch J.M., MacMillan A.M. FRET analysis of in vivo dimerization by RNA-editing enzymes. J. Biol. Chem. 2006, 281:16530-16535.
24. Chiu Y.L., Greene W.C. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 2008, 26:317-353.
25. Cho D.S., Yang W., Lee J.T., Shiekhattar R., Murray J.M., Nishikura K. Requirement of dimerization for RNA editing activity of adenosine deaminases acting on RNA. J. Biol. Chem. 2003, 278:17093-17102.
26. Clerzius G., Gélinas J.F., Daher A., Bonnet M., Meurs E.F., Gatignol A. ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication. J. Virol. 2009, 83:10119-10128.
27. Damania B. Oncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis. Nat. Rev. Microbiol. 2004, 2:656-668.
28. Desterro J.M., Keegan L.P., Lafarga M., Berciano M.T., O'Connell M., Carmo-Fonseca M. Dynamic association of RNA-editing enzymes with the nucleolus. J. Cell Sci. 2003, 116:1805-1818.
29. Desterro J.M.P., Keegan L.P., Jaffray E., Hay R.T., O'Connell M.A., Carmo-Fonseca M. SUMO-1 modification alters ADAR1 editing activity. Mol. Biol. Cell 2005, 16:5115-5126.
30. Ding S.W. RNA-based antiviral immunity. Nat. Rev. Immunol. 2010, 10:632-644.
31. Doria M., Neri F., Gallo A., Farace M.G., Michienzi A. Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection. Nucleic Acids Res. 2009, 37:5848-5858.
32. Eckmann C.R., Neunteufl A., Pfaffstetter L., Jantsch M.F. The human but not the xenopus RNA-editing enzyme ADAR1 has an atypical nuclear localization signal and displays the characteristics of a shuttling protein. Mol. Biol. Cell 2001, 12:1911-1924.
33. Emmott E., Wise H., Loucaides E.M., Matthews D.A., Digard P., Hiscox J.A. Quantitative proteomics using SILAC coupled to LC-MS/MS reveals changes in the nucleolar proteome in influenza A virus-infected cells. J. Proteome Res. 2010, 9:5335-5345.
34. Felder M.P., Laugier D., Yatsula B., Dezélée P., Calothy G., Marx M. Functional and biological properties of an avian variant long terminal repeat containing multiple A to G conversions in the U3 sequence. J. Virol. 1994, 68:4759-4767.
35. Feng Y., Sansam C.L., Singh M., Emeson R.B. Altered RNA editing in mice lacking ADAR2 autoregulation. Mol. Cell. Biol. 2006, 26:480-488.
36. Fierro-Monti I., Mathews M.B. Proteins binding to duplexed RNA: one motif, multiple functions. Trends Biochem. Sci. 2000, 25:241-246.
37. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 2008, 9:102-114.
38. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Gonçales F.L., Häussinger D., Diago M., Carosi G., Dhumeaux D., Craxi A., Lin A., Hoffman J., Yu J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 2002, 347:975-982.
39. Fritz J., Strehblow A., Taschner A., Schopoff S., Pasierbek P., Jantsch M.F. RNA-regulated interaction of transportin-1 and exportin-5 with the double-stranded RNA-binding domain regulates nucleocytoplasmic shuttling of ADAR1. Mol. Cell. Biol. 2009, 29:1487-1497.
40. Gan Z., Zhao L., Yang L., Huang P., Zhao F., Li W., Liu Y. RNA editing by ADAR2 is metabolically regulated in pancreatic islets and beta cells. J. Biol. Chem. 2006, 281:33386-33394.
41. Gandy S.Z., Linnstaedt S.D., Muralidhar S., Cashman K.A., Rosenthal L.J., Casey J.L. RNA editing of the human herpesvirus 8 kaposin transcript eliminates its transforming activity and is induced during lytic replication. J. Virol. 2007, 81:13544-13551.
42. Garaigorta U., Chisari F.V. Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe 2009, 6:513-522.
43. George C.X., Samuel C.E. Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. Proc. Natl Acad. Sci. USA 1999, 96:4621-4626.
44. George C.X., Samuel C.E. Characterization of the 5'-flanking region of the human RNA- specific adenosine deaminase ADAR1 gene and identification of an interferon-inducible ADAR1 promoter. Gene 1999, 229:203-213.
45. George C.X., Wagner M.V., Samuel C.E. Expression of interferon-inducible RNA adenosine deaminase ADAR1 during pathogen infection and mouse embryo development involves tissue-selective promoter utilization and alternative splicing. J. Biol. Chem. 2005, 280:15020-15028.
46. George C.X., Das S., Samuel C.E. Organization of the mouse RNA-specific adenosine deaminase Adar1 gene 5'-region and demonstration of STAT1-independent, STAT2-dependent transcriptional activation by interferon. Virology 2008, 380:338-343.
47. George C.X., Gan Z., Liu Y., Samuel C.E. Adenosine deaminases acting on RNA (ADARs), RNA editing and interferon action. J. Interferon Cytokine Res. 2011, 31(1):99-117. 10.1089/jir.2010.0097.
48. Gerber A., O'Connell M.A., Keller W. Two forms of human double-stranded RNA-specific editase 1 (hRED1) generated by the insertion of an Alu cassette. RNA 1997, 3:453-463.
49. Gott J.M., Emeson R.B. Functions and mechanisms of RNA editing. Annu. Rev. Genet. 2000, 34:499-531.
50. Grande-Pérez A., Sierra S., Castro M.G., Domingo E., Lowenstein P.R. Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity. Proc. Natl Acad. Sci. USA 2002, 99:12938-12943.
51. Grande-Pérez A., Lázaro E., Lowenstein P., Domingo E., Manrubia S.C. Suppression of viral infectivity through lethal defection. Proc. Natl Acad. Sci. USA 2005, 102:4448-4452.
52. Greenberger S., Levanon E.Y., Paz-Yaacov N., Barzilai A., Safran M., Osenberg S., Amariglio N., Rechavi G., Eisenberg E. Consistent levels of A-to-I RNA editing across individuals in coding sequences and non-conserved Alu repeats. BMC Genomics 2010, 11:608. 10.1186/1471-2164-11-608.
53. Gu R., Zhang Z., Decerbo J.N., Carmichael G.G. Gene regulation by sense-antisense overlap of polyadenylation signals. RNA 2009, 15:1154-1163.
54. Habig J.W., Dale T., Bass B.L. miRNA editing-we should have inosine this coming. Mol. Cell 2007, 25:792-793.
55. Habjan M., Pichlmair A., Elliott R.M., Overby A.K., Glatter T., Gstaiger M., Superti-Furga G., Unge H., Weber F. NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J. Virol. 2009, 83:4365-4375.
56. Hajjar A.M., Linial M.L. Modification of retroviral RNA by double-stranded RNA adenosine deaminase. J. Virol. 1995, 69:5878-5882.
57. Hall W.W., Lamb R.A., Choppin P.W. Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. Proc. Natl Acad. Sci. USA 1979, 76:2047-2051.
58. Hartner J.C., Schmittwolf C., Kispert A., Muller A.M., Higuchi M., Seeburg P.H. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J. Biol. Chem. 2004, 279:4894-4902.
59. Hartner J.C., Walkley C.R., Lu J., Orkin S.H. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat. Immunol. 2009, 10:109-115.
60. Hartwig D., Schoeneich L., Greeve J., Schutte C., Dorn I., Kirchner H., Hennig H. Interferon-alpha stimulation of liver cells enhances hepatitis delta virus RNA editing in early infection. J. Hepatol. 2004, 41:667-672.
61. Heale B.S., Keegan L.P., McGurk L., Michlewski G., Brindle J., Stanton C.M., Caceres J.F., O'Connell M.A. Editing independent effects of ADARs on the miRNA/siRNA pathways. EMBO J. 2009, 28:3145-3156.
62. Herbert A., Rich A. The role of binding domains for dsRNA and Z-DNA in the in vivo editing of minimal substrates by ADAR1. Proc. Natl Acad. Sci. USA 2001, 98:12132-12137.
63. Herbert A., Alfken J., Kim Y.G., Mian I.S., Nishikura K., Rich A. A Z-DNA binding domain present in the human editing enzyme, double-stranded RNA adenosine deaminase. Proc. Natl Acad. Sci. USA 1997, 94:8421-8426.
64. Higuchi M., Single F.N., Köhler M., Sommer B., Sprengel R., Seeburg P.H. RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell 1993, 75:1361-1370.
65. Higuchi M., Stefan M., Single F.N., Hartner J., Rozov A., Burnashev N., Feldmeyer D., Sprengel R., Seeburg P.H. Point mutation in an ampa receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 2000, 406:78-81.
66. Horikami S.M., Moyer S.A. Double-stranded RNA adenosine deaminase activity during measles virus infection. Virus Res. 1995, 36:87-96.
67. Hundley H.A., Bass B.L. ADAR editing in double-stranded UTRs and other noncoding RNA sequences. Trends Biochem. Sci. 2010, 35:377-383.
68. Iizasa H., Wulff B.E., Alla N.R., Maragkakis M., Megraw M., Hatzigeorgiou A., Iwakiri D., Takada K., Wiedmer A., Showe L., Lieberman P., Nishikura K. Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. J. Biol. Chem. 2010, 285:33358-33370.
69. Jacobs M.M., Fogg R.L., Emeson R.B., Stanwood G.D. ADAR1 and ADAR2 expression and editing activity during forebrain development. Dev. Neurosci. 2009, 31:223-237.
70. Jayan G.C., Casey J.L. Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2. J. Virol. 2002, 76:3819-3827.
71. Jayan G.C., Casey J.L. Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression. J. Virol. 2002, 76:12399-12404.
72. Jayan G.C., Casey J.L. Effects of conserved RNA secondary structures on hepatitis delta virus genotype I RNA editing, replication, and virus production. J. Virol. 2005, 79:11187-11193.
73. Jepson J.E., Reenan R.A. RNA editing in regulating gene expression in the brain. Biochim. Biophys. Acta 2008, 1779:459-470.
74. Kawahara Y., Zinshteyn B., Chendrimada T.P., Shiekhattar R., Nishikura K. RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Rep. 2007, 8:763-769.
75. Kawahara Y., Zinshteyn B., Sethupathy P., Iizasa H., Hatzigeorgiou A.G., Nishikura K. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 2007, 315:1137-1140.
76. Kawahara Y., Megraw M., Kreider E., Iizasa H., Valente L., Hatzigeorgiou A.G., Nishikura K. Frequency and fate of microRNA editing in human brain. Nucleic Acids Res. 2008, 36:5270-5280.
77. Kawakubo K., Samuel C.E. Human RNA-specific adenosine deaminase (ADAR1) gene specifies transcripts that initiate from a constitutively active alternative promoter. Gene 2000, 258:165-172.
78. Kim U., Garner T.L., Sanford T., Speicher D., Murray J.M., Nishikuraaa K. Purification and characterization of double-stranded RNA adenosine deaminase from bovine nuclear extracts. J. Biol. Chem. 1994, 269:13480-13489.
79. Kim U., Wang Y., Sanford T., Zeng Y., Nishikura K. Molecular cloning of c DNA for double-stranded-RNA adenosine-deaminase, a candidate enzyme for nuclear-RNA editing. Proc. Natl Acad. Sci. USA 1994, 91:11457-11461.
80. Kim Y.G., Muralinath M., Brandt T., Pearcy M., Hauns K., Lowenhaupt K., Jacobs B.L., Rich A. A role for Z-DNA binding in vaccinia virus pathogenesis. Proc. Natl Acad. Sci. USA 2003, 100:6974-6979.
81. Kim D.D., Kim T.T., Walsh T., Kobayashi Y., Matise T.C., Buyske S., Gabriel A. Widespread RNA editing of embedded Alu elements in the human transcriptome. Genome Res. 2004, 14:1719-1725.
82. Knipe D., Howley P.M., Griffin D.E., Lamb R.A., Martin M.A., Roizman B., Straus S.E. Fields Virology 2007, Lippincott Williams and Wilkins, Philadelphia. 5th ed.
83. Kuhen K.L., Samuel C.E. Isolation of the interferon-inducible RNA-dependent protein kinase PKR promoter and identification of a novel DNA element within the 5'-flanking region of human and mouse Pkr genes. Virology 1997, 227:119-130.
84. Kumar M., Carmichael G.G. Nuclear antisense RNA induces extensive adenosine modifications and nuclear retention of target transcripts. Proc. Natl Acad. Sci. USA 1997, 94:3542-3547.
85. Lai F., Drakas R., Nishikura K. Mutagenic analysis of double-stranded-RNA adenosine-deaminase, a candidate enzyme for RNA editing of glutamate-gated ion-channel transcripts. J. Biol. Chem. 1995, 270:17098-17105.
86. Lai F., Chen C.X., Carter K.C., Nishikura K. Editing of glutamate receptor B subunit ion channel RNAs by four alternatively spliced DRADA2 double-stranded RNA adenosine deaminases. Mol. Cell. Biol. 1997, 17:2413-2424.
87. Lehmann K.A., Bass B.L. Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities. Biochemistry 2000, 39:12875-12884.
88. Lei M., Liu Y., Samuel C.E. Adenovirus VAI RNA antagonizes the RNA-editing activity of the ADAR adenosine deaminase. Virology 1998, 245:188-196.
89. Lemon S.M. Induction and evasion of innate antiviral responses by hepatitis C virus. J. Biol. Chem. 2010, 285:22741-22747.
90. Levanon E.Y., Eisenberg E., Yelin R., Nemzer S., Hallegger M., Shemesh R., Fligelman Z.Y., Shoshan A., Pollock S.R., Sztybel D., Olshansky M., Rechavi G., Jantsch M.F. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat. Biotechnol. 2004, 22:1001-1005.
91. Levanon E.Y., Hallegger M., Kinar Y., Shemesh R., Djinovic-Carugo K., Rechavi G., Jantsch M.F., Eisenberg E. Evolutionarily conserved human targets of adenosine to inosine RNA editing. Nucleic Acids Res. 2005, 33:1162-1168.
92. Li Z., Wolff K.C., Samuel C.E. RNA adenosine deaminase ADAR1 deficiency leads to increased activation of protein kinase PKR and reduced vesicular stomatitis virus growth following interferon treatment. Virology 2010, 396:316-322.
93. Liebert U.G., Baczko K., Budka H., Ter Meulen V. Restricted expression of measles virus proteins in brains from cases of subacute sclerosing panencephalitis. J. Gen. Virol. 1986, 67:2435-2444.
94. Linnstaedt S.D., Kasprzak W.K., Shapiro B.A., Casey J.L. The fraction of RNA that folds into the correct branched secondary structure determines hepatitis delta virus type 3 RNA editing levels. RNA 2009, 15:1177-1187.
95. Liu Y., Samuel C.E. Mechanism of interferon action: Functionally distinct RNA-binding and catalytic domains in the interferon-inducible, double-stranded RNA- specific adenosine deaminase. J. Virol. 1996, 70:1961-1968.
96. Liu Y., Samuel C.E. Editing of glutamate receptor subunit B pre-mRNA by splice-site variants of interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1. J. Biol. Chem. 1999, 274:5070-5077.
97. Liu Z., Batt D.B., Carmichael G.G. Targeted nuclear antisense RNA mimics natural antisense-induced degradation of polyoma virus early RNA. Proc. Natl Acad. Sci. USA 1994, 91:4258-4262.
98. Liu Y., George C.X., Patterson J.B., Samuel C.E. Functionally distinct double-stranded RNA-binding domains associated with alternative splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase. J. Biol. Chem. 1997, 272:419-4428.
99. Liu Y., Herbert A., Rich A., Samuel C.E. Double-stranded RNA-specific adenosine deaminase: nucleic acid binding properties. Methods 1998, 15:199-205.
100. Liu Y., Emeson R.B., Samuel C.E. Serotonin-2c receptor pre-mRNA editing in rat brain and in vitro by splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1. J. Biol. Chem. 1999, 274:18351-18358.
101. Liu Y., Lei M., Samuel C.E. Chimeric double-stranded RNA-specific adenosine deaminase ADAR1 proteins reveal functional selectivity of double-stranded RNA-binding domains from ADAR1 and protein kinase PKR. Proc. Natl Acad. Sci. USA 2000, 97:12541-12546.
102. Liu Y., Wolff K.C., Jacobs B.L., Samuel C.E. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity. Virology 2001, 289:378-387.
103. Luciano D.J., Mirsky H., Vendetti N.J., Maas S. RNA editing of a miRNA precursor. RNA 2004, 10:1174-1177.
104. Luo G.X., Chao M., Hsieh S.Y., Sureau C., Nishikura K., Taylor J. A specific base transition occurs on replicating hepatitis delta virus-RNA. J. Virol. 1990, 64:1021-1027.
105. Maas S., Gommans W.M. Novel exon of mammalian ADAR2 extends open reading frame. PLoS ONE 2009, 4:e4225.
106. Maas S., Gommans W.M. Identification of a selective nuclear import signal in adenosine deaminases acting on RNA. Nucleic Acids Res. 2009, 37:5822-5829.
107. Maas S., Rich A., Nishikura K. A-to-I RNA editing: recent news and residual mysteries. J. Biol. Chem. 2003, 278:1391-1394.
108. Macbeth M.R., Schubert H.L., Vandemark A.P., Lingam A.T., Hill C.P., Bass B.L. Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing. Science 2005, 309:1534-1539.
109. Malim M.H. APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2009, 364:675-687.
110. Markle D., Das S., Ward S.V., Samuel C.E. Functional analysis of the KCS-like element of the interferon-inducible RNA-specific adenosine deaminase ADAR1 promoter. Gene 2003, 304:143-149.
111. Martínez I., Melero J.A. A model for the generation of multiple A to G transitions in the human respiratory syncytial virus genome: predicted RNA secondary structures as substrates for adenosine deaminases that act on RNA. J. Gen. Virol. 2002, 83:1445-1455.
112. Martínez I., Dopazo J., Melero J.A. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. J. Gen. Virol. 1997, 78:2419-22429.
113. McAllister C.S., Toth A.M., Zhang P., Devaux P., Cattaneo R., Samuel C.E. Mechanisms of protein kinase PKR-mediated amplification of beta interferon induction by C protein-deficient measles virus. J. Virol. 2010, 84:380-386.
114. McCormack S.J., Thomis D.C., Samuel C.E. Mechanism of interferon action: identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2 alpha protein kinase. Virology 1992, 188:47-56.
115. Melcher T., Maas S., Herb A., Sprengel R., Higuchi M., Seeburg P.H. RED2, a brain-specific member of the RNA-specific adenosine deaminase family. J. Biol. Chem. 1996, 271:31795-31798.
116. Melcher T., Maas S., Herb A., Sprengel R., Seeburg P.H., Higuchi M. A mammalian RNA editing enzyme. Nature 1996, 379:460-464.
117. Mittaz L., Scott H.S., Rossier C., Seeburg P.H., Higuchi M., Antonarakis S.E. Cloning of a human RNA editing deaminase (ADARB1) of glutamate receptors that maps to chromosome 21q22.3. Genomics 1997, 41:210-217.
118. Moss W.J., Griffin D.E. Global measles elimination. Nat. Rev. Microbiol. 2006, 4:900-908.
119. Muralidhar S., Pumfery A.M., Hassani M., Sadaie M.R., Kishishita M., Brady J.N., Doniger J., Medveczky P., Rosenthal L.J. Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J. Virol. 1998, 72:4980-4988.
120. Murphy D.F., Dimock K., Kang C.Y. Numerous transitions in human parainfluenza virus 3 RNA recovered from persistently infected cells. Virology 1991, 181:760-763.
121. Ngamurulert S., Limjindaporn T., Auewaraku P. Identification of cellular partners of Influenza A virus (H5N1) non-structural protein NS1 by yeast two-hybrid system. Acta Virol. 2009, 53:153-159.
122. Nie Y., Hammond G.L., Yang J.H. Double-stranded RNA deaminase ADAR1 increases host susceptibility to virus infection. J. Virol. 2007, 81:917-923.
123. Nishikura K. Functions and regulation of RNA editing by ADAR deaminases. Annu. Rev. Biochem. 2010, 79:321-349.
124. Niswender C.M., Copeland S.C., Herrick-Davis K., Emeson R.B., Sanders-Bush E. RNA editing of the human serotonin 5-hydroxytryptamine 2c receptor silences constitutive activity. J. Biol. Chem. 1999, 274:9472-9478.
125. O'Connell M.A., Krause S., Higuchi M., Hsuan J.J., Totty N.F., Jenny A., Keller W. Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase. Mol. Cell. Biol. 1995, 15:1389-1397.
126. O'Connell M.A., Gerbe R.A., Keller W. Purification of human double-stranded RNA-specific editase 1 (hRED1) involved in editing of brain glutamate receptor B pre-mRNA. J. Biol. Chem. 1997, 272:473-478.
127. O'Hara P., Nichol S., Horodyski F., Holland J. Vesicular stomatitis virus defective interfering particles can contain extensive genomic sequence rearrangements and base substitutions. Cell 1984, 36:915-924.
128. Oldstone M.B. Modeling subacute sclerosing panencephalitis in a transgenic mouse system: uncoding pathogenesis of disease and illuminating components of immune control. Curr. Top. Microbiol. Immunol. 2009, 330:31-54.
129. Oldstone M.B., Lewicki H., Thomas D., Tishon A., Dales S., Patterson J., Manchester M., Homann D., Naniche D., Holz A. Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease. Cell 1999, 98:629-640.
130. Osenberg S., Dominissini D., Rechavi G., Eisenberg E. Widespread cleavage of A-to-I hyperediting substrates. RNA 2009, 2009:1632-1639.
131. Palma E.L., Huang A. Cyclic production of vesicular stomatitis virus caused by defective interfering particles. J. Infect. Dis. 1974, 129:402-410.
132. Patterson J.B., Samuel C.E. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol. Cell. Biol. 1995, 15:5376-5388.
133. Patterson J.B., Thomis D.C., Hans S.L., Samuel C.E. Mechanism of interferon action - double-stranded RNA-specific adenosine-deaminase from human-cells is inducible by alpha-interferon and gamma-interferon. Virology 1995, 210:508-511.
134. Patterson J.B., Cornu T.I., Redwine J., Dales S., Lewicki H., Holz A., Thomas D., Billeter M.A., Oldstone M.B. Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease. Virology 2001, 291:215-225.
135. Peacock H., Fostvedt E., Beal P.A. Minor-Groove-Modulating Adenosine Replacements Control Protein Binding and RNAi Activity in siRNAs. ACS Chem. Biol. 2010, 5:1115-1124.
136. Pedersen I.M., Cheng G., Wieland S., Volinia S., Croce C.M., Chisari F.V., David M. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007, 449:919-922.
137. Pfeffer S., Zavolan M., Grässer F.A., Chien M., Russo J.J., Ju J., John B., Enright A.J., Marks D., Sander C., Tuschl T. Identification of virus-encoded microRNAs. Science 2004, 304:734-736.
138. Pfeffer S., Sewer A., Lagos-Quintana M., Sheridan R., Sander C., Grässer F.A., van Dyk L.F., Ho C.K., Shuman S., Chien M., Russo J.J., Ju J., Randall G., Lindenbach B.D., Rice C.M., Simon V., Ho D.D., Zavolan M., Tuschl T. Identification of microRNAs of the herpesvirus family. Nat. Methods 2005, 2:269-776.
139. Phuphuakrat A., Kraiwong R., Boonarkart C., Lauhakirti D., Lee T.H., Auewarakul P. Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins. J. Virol. 2008, 82:10864-10872.
140. Placido D., Brown B.A., Lowenhaupt K., Rich A., Athanasiadis A. A left-handed RNA double helix bound by the Z alpha domain of the RNA-editing enzyme ADAR1. Structure 2007, 15:395-404.
141. Polson A.G., Ley H.L., Bass B.L., Casey J.L. Hepatitis delta virus RNA editing is highly specific for the amber/W site and is suppressed by hepatitis delta antigen. Mol. Cell. Biol. 1998, 18:1919-1926.
142. Poulsen H., Nilsson J., Damgaard C.K., Egebjerg J., Kjems J. Crm1 mediates the export of ADAR1 through a nuclear export signal within the Z-DNA binding domain. Mol. Cell. Biol. 2001, 21:7862-7871.
143. Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 2008, 89:1-47.
144. Rebagliati M.R., Melton D.A. Antisense RNA injections in fertilized frog eggs reveal an RNA duplex unwinding activity. Cell 1987, 48:599-605.
145. Ronald P.C., Beutler B. Plant and animal sensors of conserved microbial signatures. Science 2010, 330:1061-1064.
146. Rueda P., García-Barreno B., Melero J.A. Loss of conserved cysteine residues in the attachment (G) glycoprotein of two human respiratory syncytial virus escape mutants that contain multiple A-G substitutions (hypermutations). Virology 1994, 198:653-662.
147. Rueter S.M., Dawson R.T., Emeson R.B. Regulation of alternative splicing by RNA editing. Nature 1999, 399:75-80.
148. Sakurai M., Yano T., Kawabata H., Ueda H., Suzuki T. Inosine cyanoethylation identifies A-to-I RNA editing sites in the human transcriptome. Nat. Chem. Biol. 2010, 6:733-740.
149. Samuel C.E. Mechanism of interferon action: Phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc. Natl Acad. Sci. USA 1979, 76:600-604.
150. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 2001, 14:778-809.
151. Samuel C.E. RNA editing minireview series. J. Biol. Chem. 2003, 278:1389-1390.
152. Sansam C.L., Wells K.S., Emeson R.B. Modulation of RNA editing by functional nucleolar sequestration of ADAR2. Proc. Natl Acad. Sci. USA 2003, 100:14018-14023.
153. Sato S., Wong S.K., Lazinski D.W. Hepatitis delta virus minimal substrates competent for editing by ADAR1 and ADAR2. J. Virol. 2001, 75:8547-8555.
154. Sato S., Cornillez-Ty C., Lazinski D.W. By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber/W editing and its own expression. J. Virol. 2004, 78:8120-8134.
155. Scadden A.D. The RISC subunit Tudor-SN binds to hyper-edited double-stranded RNA and promotes its cleavage. Nat. Struct. Mol. Biol. 2005, 12:489-496.
156. Scadden A.D. Inosine-containing dsRNA binds a stress-granule-like complex and downregulates gene expression in trans. Mol. Cell 2007, 28:491-500.
157. Scadden A.D., O'Connell M.A. Cleavage of dsRNAs hyper-edited by ADARs occurs at preferred editing sites. Nucleic Acids Res. 2005, 33:5954-5964.
158. Scadden A.D., Smith C.W. A ribonuclease specific for inosine-containing RNA: a potential role in antiviral defence?. EMBO J. 1997, 16:2140-2149.
159. Scadden A.D., Smith C.W. RNAi is antagonized by A-->I hyper-editing. EMBO Rep. 2001, (12):1107-1111.
160. Scadden A.D., Smith C.W. Specific cleavage of hyper-edited dsRNAs. EMBO J. 2001, 20:4243-4252.
161. Schmid A., Spielhofer P., Cattaneo R., Baczko K., ter Meulen V., Billeter M.A. Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus. Virology 1992, 188:910-915.
162. Schwartz T., Rould M.A., Lowenhaupt K., Herbert A., Rich A. Crystal structure of the Z domain of the human editing enzyme ADAR1 bound to left-handed Z-DNA. Science 1999, 284:1841-1845.
163. Seeburg P.H., Hartner J. Regulation of ion channel/neurotransmitter receptor function by RNA editing. Curr. Opin. Neurobiol. 2003, 13:279-283.
164. Serra M.J., Smolter P.E., Westhof E. Pronounced instability of tandem IU base pairs in RNA. Nucleic Acids Res. 2004, 32:1824-1828.
165. Sharmeen L., Bass B., Sonenberg N., Weintraub H., Groudine M. Tat-dependent adenosine-to-inosine modification of wild-type transactivation response RNA. Proc. Natl Acad. Sci. USA 1991, 88:8096-8100.
166. Shtrichman R., Heithoff D.M., Mahan M.J., Samuel C.E. Tissue selectivity of interferon-stimulated gene expression in mice infected with dam(+) versus dam(-) Salmonella enterica Serovar typhimurium strains. Infect. Immun. 2002, 70:5579-5588.
167. Singh M., Kesterson R.A., Jacobs M.M., Joers J.M., Gore J.C., Emeson R.B. Hyperphagia-mediated obesity in transgenic mice misexpressing the RNA-editing enzyme ADAR2. J. Biol. Chem. 2007, 282:22448-22459.
168. Skalsky R.L., Cullen B.R. Viruses, microRNAs, and host interactions. Annu. Rev. Microbiol. 2010, 64:123-141.
169. Slavov D., Gardiner K. Phylogenetic comparison of the pre-mRNA adenosine deaminase ADAR2 genes and transcripts: conservation and diversity in editing site sequence and alternative splicing patterns. Gene 2002, 299:83-94.
170. St.Laurent G., Savva Y.A., Reenan R. Enhancing non-coding RNA information content with ADAR editing. Neurosci. Lett. 2009, 466:89-98.
171. Stefl R., Xu M., Skrisovska L., Emeson R.B., Allain F.H. Structure and specific RNA binding of ADAR2 double-stranded RNA binding motifs. Structure 2006, 14:345-355.
172. Strehblow A., Hallegger M., Jantsch M.F. Nucleocytoplasmic distribution of human RNA-editing enzyme ADAR1 is modulated by double-stranded RNA-binding domains, a leucine-rich export signal, and a putative dimerization domain. Mol. Biol. Cell 2002, 13:3822-3835.
173. Strobel S.A., Cech T.R., Usman N., Beigelman L. The 2, 6-diaminopurine riboside.5-methylisocytidine wobble base pair: an isoenergetic substitution for the study of G.U pairs in RNA. Biochemistry 1994, 33:13824-13835.
174. Suspène R., Renard M., Henry M., Guétard D., Puyraimond-Zemmour D., Billecocq A., Bouloy M., Tangy F., Vartanian J.P., Wain-Hobson S. Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs. Nucleic Acids Res. 2008, 36(12):e72.
175. Taylor J.M. Replication of human hepatitis delta virus: recent developments. Trends Microbiol. 2003, 11:185-190.
176. Taylor D.R., Puig M., Darnell M.E.R., Mihalik K., Feinstone S.M. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. J. Virol. 2005, 79:6291-6298.
177. tenOever B.R., Ng S.L., Chua M.A., McWhirter S.M., García-Sastre A., Maniatis T. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 2007, 315:1274-1278.
178. Toth A.M., Zhang P., Das S., George C.X., Samuel C.E. Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase. Prog. Nucleic Acid Res. Mol. Biol. 2006, 81:369-434.
179. Toth A.M., Li Z., Cattaneo R., Samuel C.E. RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR. J. Biol. Chem. 2009, 284:29350-29356.
180. Valente L., Nishikura K. ADAR gene family and A-to-I RNA editing: diverse roles in posttranscriptional gene regulation. Prog. Nucleic Acid Res. Mol. Biol. 2005, 79:299-338.
181. Valente L., Nishikura K. RNA binding-independent dimerization of adenosine deaminases acting on RNA and dominant negative effects of nonfunctional subunits on dimer functions. J. Biol. Chem. 2007, 282:16054-16061.
182. Valentine R., Smith G.L. Inhibition of the RNA polymerase III-mediated dsDNA-sensing pathway of innate immunity by vaccinia virus protein E3. J. Gen. Virol. 2010, 91:2221-2229.
183. Vitali P., Scadden A.D. Double-stranded RNAs containing multiple IU pairs are sufficient to suppress interferon induction and apoptosis. Nat. Struct. Mol. Biol. 2010, 17:1043-1050.
184. Wagner R.W., Smith J.E., Cooperman B.S., Nishikura K. A double-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammalian cells and Xenopus eggs. Proc. Natl Acad. Sci. USA 1989, 86:2647-2651.
185. Wang Y., Samuel C.E. Adenosine deaminase ADAR1 increases gene expression at the translational level by decreasing protein kinase PKR-dependent eIF-2alpha phosphorylation. J. Mol. Biol. 2009, 393:777-787.
186. Wang Y., Zeng Y., Murray J.M., Nishikura K. Genomic organization and chromosomal location of the human dsRNA adenosine deaminase gene: the enzyme for glutamate-activated ion channel RNA editing. J. Mol. Biol. 1995, 254:184-195.
187. Wang Q., Miyakoda M., Yang W., Khillan J., Stachura D.L., Weiss M.J., Nishikura K. Stress-induced apoptosis associated with null mutation of Adar1 RNA editing deaminase gene. J. Biol. Chem. 2004, 279:4952-4961.
188. Ward S.V., George C.X., Welch M.J., Liou L.Y., Hahm B., Lewicki H., de la Torre J.C., Samuel C.E., Oldstone M.B. RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis. Proc. Natl. Acad. Sci. USA. 2011, Epub 2010 Dec 20. doi:10.1073/pnas.101724110.
189. Weier H.U.G., George C.X., Greulich K.M., Samuel C.E. The interferon-inducible, double-stranded RNA-specific adenosine deaminase gene (DSRAD) maps to human chromosome 1q21.1-21.2. Genomics 1995, 30:372-375.
190. Weier H.U.G., George C.X., Lersch R.A., Breitweser S., Cheng J.F., Samuel C.E. Assignment of the RNA-specific adenosine deaminase gene (Adar) to mouse chromosome 3f2 by in situ hybridization. Cytogenet. Cell Genet. 2000, 89:214-215.
191. Welzel T.M., Morgan T.R., Bonkovsky H.L., Naishadham D., Pfeiffer R.M., Wright E.C., Hutchinson A.A., Crenshaw A.T., Bashirova A., Carrington M., Dotrang M., Sterling R.K., Lindsay K.L., Fontana R.J., Lee W.M., Di Bisceglie A.M., Ghany M.G., Gretch D.R., Chanock S.J., Chung R.T., O'Brien T.R. Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 2009, 49:1847-1858. HALT-C Trial Group.
192. Wong S.K., Lazinski D.W. Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1. Proc. Natl Acad. Sci. USA 2002, 99:15118-15123.
193. Wong T.C., Ayata M., Ueda S., Hirano A. Role of biased hypermutation in evolution of subacute sclerosing panencephalitis virus from progenitor acute measles virus. J. Virol. 1991, 65:2191-2199.
194. XuFeng R., Boyer M.J., Shen H., Li Y., Yu H., Gao Y., Yang Q., Wang Q., Cheng T. ADAR1 is required for hematopoietic progenitor cell survival via RNA editing. Proc. Natl Acad. Sci. USA 2009, 106:17763-17768.
195. Yang W.D., Wang Q.D., Howell K.L., Lee J.T., Cho D.S.C., Murray J.M., Nishikura K. ADAR1 RNA deaminase limits short interfering RNA efficacy in mammalian cells. J. Biol. Chem. 2005, 280:3946-3953.
196. Yang W., Chendrimada T.P., Wang Q., Higuchi M., Seeburg P.H., Shiekhattar R., Nishikura K. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat. Struct. Mol. Biol. 2006, 13:13-21.
197. Yeo J., Goodman R.A., Schirle N.T., David S.S., Beal P.A. RNA editing changes the lesion specificity for the DNA repair enzyme NEIL1. Proc. Natl. Acad. Sci. USA 2010, 107:20715-20719.
198. Zahn R.C., Schelp I., Utermöhlen O., von Laer D. A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus. J. Virol. 2007, 81:457-464.